Viral Inactivation Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the global viral inactivation market looks promising with opportunities in applications, such as stem cell products, blood and blood related products, tissues & tissue related products, cellular & gene therapy products, and vaccines & therapeutics. The global viral inactivation market is expected to grow with a CAGR of 11%-13% from 2020 to 2025. The major drivers for this market are rising investment in the life science sector, increasing launches & approvals for new drugs, and government support in funding for the development of the pharmaceutical and biopharmaceutical industries.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global viral inactivation market report, please download the report brochure.
In this market, kits and reagents is the largest product type of viral inactivation, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the viral inactivation market are given below:
The study includes trends and forecast for the global viral inactivation market by product, method, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growth in the pharmaceutical and biotechnology industries and rising R&D spending for new drug development.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period because increasing investment to find alternative therapies has increased the development of new drugs and introduction of biologics and other cellular & gene therapy products.
North America will remain the largest region over the forecast period due to the presence of advanced healthcare infrastructure and significant expenditure on research and development activities by the government and companies in the region.
Features of the Global Viral Inactivation Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global viral inactivation market by product (kits & reagents, services, and systems & accessories), method (solvent detergent, pasteurization, and other methods), application (stem cell products, blood & blood products, tissues & tissue products, cellular & gene therapy products, and vaccines & therapeutics), end user (pharmaceutical and biotechnology companies, CROs, academic research institutes, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global viral inactivation market?
Q.5 What are the business risks and threats to the global viral inactivation market?
Q.6 What are the emerging trends in this viral inactivation market and the reasons behind them?
Q.7 What are some changing demands of customers in this viral inactivation market?
Q.8 What are the new developments in this viral inactivation market? Which companies are leading these developments?
Q.9 Who are the major players in this viral inactivation market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this viral inactivation market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global viral inactivation market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Kits & Reagents, Services, and Systems & Accessories), Method (Solvent Detergent, Pasteurization, and Other Methods), Application (Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics), and End User (Pharmaceutical And Biotechnology Companies, CROs, Academic Research Institutes, and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the global viral inactivation market looks promising with opportunities in applications, such as stem cell products, blood and blood related products, tissues & tissue related products, cellular & gene therapy products, and vaccines & therapeutics. The global viral inactivation market is expected to grow with a CAGR of 11%-13% from 2020 to 2025. The major drivers for this market are rising investment in the life science sector, increasing launches & approvals for new drugs, and government support in funding for the development of the pharmaceutical and biopharmaceutical industries.
A total of XX figures / charts and XX tables are provided in this more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global viral inactivation market report, please download the report brochure.
In this market, kits and reagents is the largest product type of viral inactivation, whereas pharmaceutical and biotechnology companies is the largest end user. Growth in various segments of the viral inactivation market are given below:
The study includes trends and forecast for the global viral inactivation market by product, method, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Kits & Reagents
- Services
- Systems & Accessories
- Solvent Detergent
- Pasteurization
- Other Methods
- Stem Cell Products
- Blood and Blood Products
- Tissues & Tissue Products
- Cellular & Gene Therapy Products
- Vaccines & Therapeutics
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic Research Institutes
- Other End Users
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growth in the pharmaceutical and biotechnology industries and rising R&D spending for new drug development.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period because increasing investment to find alternative therapies has increased the development of new drugs and introduction of biologics and other cellular & gene therapy products.
North America will remain the largest region over the forecast period due to the presence of advanced healthcare infrastructure and significant expenditure on research and development activities by the government and companies in the region.
Features of the Global Viral Inactivation Market
- Market Size Estimates: Global viral inactivation market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global viral inactivation market size by various segments, such as product, method, application, and end user in terms of value.
- Regional Analysis: Global viral inactivation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different product, method, application, and end user, and region for the global viral inactivation market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global viral inactivation market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global viral inactivation market by product (kits & reagents, services, and systems & accessories), method (solvent detergent, pasteurization, and other methods), application (stem cell products, blood & blood products, tissues & tissue products, cellular & gene therapy products, and vaccines & therapeutics), end user (pharmaceutical and biotechnology companies, CROs, academic research institutes, and other end users), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global viral inactivation market?
Q.5 What are the business risks and threats to the global viral inactivation market?
Q.6 What are the emerging trends in this viral inactivation market and the reasons behind them?
Q.7 What are some changing demands of customers in this viral inactivation market?
Q.8 What are the new developments in this viral inactivation market? Which companies are leading these developments?
Q.9 Who are the major players in this viral inactivation market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this viral inactivation market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global viral inactivation market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Kits & Reagents, Services, and Systems & Accessories), Method (Solvent Detergent, Pasteurization, and Other Methods), Application (Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics), and End User (Pharmaceutical And Biotechnology Companies, CROs, Academic Research Institutes, and Other End Users)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Viral Inactivation Market Trends and Forecast
3.3: Global Viral Inactivation Market by Product
3.3.1: Kits & Reagents
3.3.2: Services
3.3.3: Systems & Accessories
3.4: Global Viral Inactivation Market by Method
3.4.1: Solvent Detergent
3.4.2: Pasteurization
3.4.3: Other Methods
3.5: Global Viral Inactivation Market by Application
3.5.1: Stem Cell Products
3.5.2: Blood & Blood Products
3.5.3: Tissues & Tissue Products
3.5.4: Cellular & Gene Therapy Products
3.5.5: Vaccines & Therapeutics
3.6: Global Viral Inactivation Market by End User
3.6.1: Pharmaceutical and Biotechnology Companies
3.6.2: Contract Research Organizations (CROs)
3.6.3: Academic Research Institutes
3.6.4: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Viral Inactivation Market by Region
4.2: North American Viral Inactivation Market
4.2.1: Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.2.2: Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.2.3: Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.2.4: Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.2.5: The United States Viral Inactivation Market
4.2.6: The Canadian Viral Inactivation Market
4.2.7: The Mexican Viral Inactivation Market
4.3: European Viral Inactivation Market
4.3.1: Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.3.2: Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.3.3: Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.3.4: Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.3.5: The Viral Inactivation Market of United Kingdom
4.3.6: The Spanish Viral Inactivation Market
4.3.7: The German Viral Inactivation Market
4.3.8: The French Viral Inactivation Market
4.4: APAC Viral Inactivation Market
4.4.1: Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.4.2: Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.4.3: Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.4.4: Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.4.5: The Chinese Viral Inactivation Market
4.4.6: The Indian Viral Inactivation Market
4.4.7: The Japanese Viral Inactivation Market
4.5: ROW Viral Inactivation Market
4.5.1: Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.5.2: Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.5.3: Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.5.4: Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.5.5: Brazilian Viral Inactivation Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Viral Inactivation Market by Product
7.1.2: Growth Opportunities for the Global Viral Inactivation Market by Method
7.1.3: Growth Opportunities for the Global Viral Inactivation Market by Application
7.1.4Growth Opportunities for the Global Viral Inactivation Market by End User
7.1.5: Growth Opportunities for the Global Viral Inactivation Market by Region
7.2: Emerging Trends in the Global Viral Inactivation Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Viral Inactivation Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Viral Inactivation Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Clean Cells
8.2: Charles River Laboratories International, Inc.
8.3: Danaher Corporation
8.4: Merck KGaA
8.5: Parker Hannifin
8.6: Rad Source Technologies
8.7: Sartorius AG
8.8: SGS S.A.
8.9: Texcell, Inc.
8.10: Viral Inactivated Plasma Systems SA
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Viral Inactivation Market Trends and Forecast
3.3: Global Viral Inactivation Market by Product
3.3.1: Kits & Reagents
3.3.2: Services
3.3.3: Systems & Accessories
3.4: Global Viral Inactivation Market by Method
3.4.1: Solvent Detergent
3.4.2: Pasteurization
3.4.3: Other Methods
3.5: Global Viral Inactivation Market by Application
3.5.1: Stem Cell Products
3.5.2: Blood & Blood Products
3.5.3: Tissues & Tissue Products
3.5.4: Cellular & Gene Therapy Products
3.5.5: Vaccines & Therapeutics
3.6: Global Viral Inactivation Market by End User
3.6.1: Pharmaceutical and Biotechnology Companies
3.6.2: Contract Research Organizations (CROs)
3.6.3: Academic Research Institutes
3.6.4: Other End Users
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Viral Inactivation Market by Region
4.2: North American Viral Inactivation Market
4.2.1: Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.2.2: Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.2.3: Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.2.4: Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.2.5: The United States Viral Inactivation Market
4.2.6: The Canadian Viral Inactivation Market
4.2.7: The Mexican Viral Inactivation Market
4.3: European Viral Inactivation Market
4.3.1: Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.3.2: Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.3.3: Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.3.4: Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.3.5: The Viral Inactivation Market of United Kingdom
4.3.6: The Spanish Viral Inactivation Market
4.3.7: The German Viral Inactivation Market
4.3.8: The French Viral Inactivation Market
4.4: APAC Viral Inactivation Market
4.4.1: Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.4.2: Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.4.3: Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.4.4: Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.4.5: The Chinese Viral Inactivation Market
4.4.6: The Indian Viral Inactivation Market
4.4.7: The Japanese Viral Inactivation Market
4.5: ROW Viral Inactivation Market
4.5.1: Market by Product: Kits & Reagents, Services, and Systems & Accessories
4.5.2: Market by Method: Solvent Detergent, Pasteurization, and Other Methods
4.5.3: Market by Application: Stem Cell Products, Blood & Blood Products, Tissues & Tissue Products, Cellular & Gene Therapy Products, and Vaccines & Therapeutics
4.5.4: Market by End User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Institutes, and Other End Users
4.5.5: Brazilian Viral Inactivation Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Viral Inactivation Market by Product
7.1.2: Growth Opportunities for the Global Viral Inactivation Market by Method
7.1.3: Growth Opportunities for the Global Viral Inactivation Market by Application
7.1.4Growth Opportunities for the Global Viral Inactivation Market by End User
7.1.5: Growth Opportunities for the Global Viral Inactivation Market by Region
7.2: Emerging Trends in the Global Viral Inactivation Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Viral Inactivation Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Viral Inactivation Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Clean Cells
8.2: Charles River Laboratories International, Inc.
8.3: Danaher Corporation
8.4: Merck KGaA
8.5: Parker Hannifin
8.6: Rad Source Technologies
8.7: Sartorius AG
8.8: SGS S.A.
8.9: Texcell, Inc.
8.10: Viral Inactivated Plasma Systems SA
